谷歌浏览器插件
订阅小程序
在清言上使用

A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year 2 interim analysis

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览11
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要